CABTREO- clindamycin phosphate/benzoyl peroxide/adapalene gel Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

cabtreo- clindamycin phosphate/benzoyl peroxide/adapalene gel

bausch health us llc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm), adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - cabtreo is indicated for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older. cabtreo is contraindicated in patients with: - known hypersensitivity to clindamycin, adapalene, benzoyl peroxide, any other components of cabtreo, or lincomycin [see warnings and precautions ( 5.1)]. - a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis [see warnings and precautions ( 5.2)]. risk summary available data with cabtreo use in pregnant women are insufficient to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with cabtreo. clindamycin in published clinical trials and observational studies with pregnant women, oral or iv administration of clindamycin has not been associated with an increased frequency of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. in animal reproduction stud

TAROCLINDIN GEL Izraelis - anglų - Ministry of Health

taroclindin gel

taro international ltd, israel - benzoyl peroxide as hydrous; clindamycin as phosphate - gel - benzoyl peroxide as hydrous 5 %w/w; clindamycin as phosphate 1 %w/w - clindamycin, combinations - mild to moderate acne vulgaris, particulary inflammatory lesions.

BENZAMYCIN TOPICAL GEL Izraelis - anglų - Ministry of Health

benzamycin topical gel

perrigo israel agencies ltd - benzoyl peroxide; erythromycin - gel - benzoyl peroxide 87.125 mg/g; erythromycin 0.8 g - benzoyl peroxide, combinations - benzoyl peroxide, combinations - for topical treatment of acne vulgaris.

BENZACLIN GEL Kanada - anglų - Health Canada

benzaclin gel

bausch health, canada inc. - clindamycin (clindamycin phosphate); benzoyl peroxide - gel - 1%; 5% - clindamycin (clindamycin phosphate) 1%; benzoyl peroxide 5% - antibiotics

BENZOYL PEROXIDE 2.5%, CLINDAMYCIN PHOSPHATE 1%, NIACINAMIDE 2% / TRETINOIN 0.05%- benzoyl peroxide 2.5%, clindamycin phosphate Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

benzoyl peroxide 2.5%, clindamycin phosphate 1%, niacinamide 2% / tretinoin 0.05%- benzoyl peroxide 2.5%, clindamycin phosphate

sincerus florida, llc - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r), clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) -

NUCARARXPAK- clindamycin phosphate,benzoyl peroxide,cetaphil kit Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

nucararxpak- clindamycin phosphate,benzoyl peroxide,cetaphil kit

nucare pharmaceuticals,inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate topical solution, clindamycin phosphate gel, and clindamycin phosphate lotion are indicated in the treatment of acne vulgaris. in view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate. (see contraindications , warnings and adverse reactions. ) clindamycin phosphate topical solution, clindamycin phosphate gel, and clindamycin phosphate lotion are contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis. acne treatmentd for the treatment of acne if you have very sensitive skin are sensitive to benzoyl peroxide - irritation becomes severe helps prevent sunburn.

Benzoyl peroxide 5% / Clindamycin 1% gel Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

benzoyl peroxide 5% / clindamycin 1% gel

aspire pharma ltd - benzoyl peroxide; clindamycin phosphate - cutaneous gel - 50mg/1gram ; 10mg/1gram

Benzoyl peroxide 5% / Clindamycin 1% gel Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

benzoyl peroxide 5% / clindamycin 1% gel

a a h pharmaceuticals ltd - benzoyl peroxide; clindamycin phosphate - cutaneous gel - 50mg/1gram ; 10mg/1gram

Benzoyl peroxide 5% / Clindamycin 1% gel Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

benzoyl peroxide 5% / clindamycin 1% gel

alliance healthcare (distribution) ltd - benzoyl peroxide; clindamycin phosphate - cutaneous gel - 50mg/1gram ; 10mg/1gram

Benzoyl peroxide 5% / Clindamycin 1% gel Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

benzoyl peroxide 5% / clindamycin 1% gel

morningside healthcare ltd - benzoyl peroxide; clindamycin phosphate - cutaneous gel - 50mg/1gram ; 10mg/1gram